The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.
Life Line aims to offer Lucent's blood-based testing through its mobile delivery model at urban and rural community health screening events.
Last week, readers were most interested in a story about the conviction of lab owner, formerly an NFL player, for genetic testing fraud.
BioAffinity Technologies said on Wednesday that it will run a study of its CyPath Lung test for early lung cancer detection in collaboration with Brooke Army Medical Center (BAMC). CyPath Lung ...
Moffit Cancer Center researchers found four "protein EpiScores" that were associated with disease-free survival, one of which was also associated with overall survival.
The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.
NEW YORK – Irish diagnostic firm Trinity Biotech announced on Wednesday that it has entered into a $25 million standby equity purchase agreement with an affiliate of its financing partner Yorkville ...
The precision cancer diagnostics firm Epredia will distribute Mindpeak's AI-based image recognition solutions for clinical diagnostics, research, and pharma development.
The interferon-gamma release assay for latent tuberculosis infection is designed for use on Diasorin's automated, high-throughput Liaison XL platform.
The certification covers assays for pertussis, malaria, chlamydia, gonorrhea, herpes, cytomegalovirus, and group B streptococcus.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results